Apply for a subscription
or request a trial

If you'd like to subscribe to Mergermarket or inquire about a trial, please contact us.

  • This field is for validation purposes and should be left unchanged.

Prefer to call or email?


+1 212 500 7537 / Email Sales Americas


+44 (0)20 7010 6326 / Email Sales EMEA


+852 2158 9764 / Email Sales Asia


+61 2 9467 6646 / Email Sales Australasia

Mergermarket in BBC Online

Chugai shares hit record on Roche takeover reports

Roche is the world’s biggest maker of cancer drugs

Chugai’s stock surged by more than 20% in Tokyo trading on Monday.

Roche, the world’s biggest maker of cancer drugs, already owns about 60% of the Japanese firm and is said to be looking to buy the remainder for about $10bn (£6bn).

According to various news outlets, a deal could come as early as this week.

Chugai has denied talks with Roche, saying in a statement made over the weekend that it was “in no way in the process of reviewing any plan to become a wholly owned subsidiary of Roche.”

Roche has owned a majority stake in Chugai, which develops oncology and arthritis drugs, for more than decade.

A successful acquisition of the Tokyo-based firm would add to the wave of global deal-making the pharmaceutical, biotech and medical products sector has seen this year.

According to Mergermarket, more than $260bn in deals were made in the first half of this year as drugmakers looked to reduce costs and find new sources of growth.

Sign in to mergermarket

Forgotten your password?

This message can be edited in Snippets > Forgotten Password message.